Production Plants

Biopharmaceutical Production Sites

Boehringer Ingelheim offers the entire production technology chain at its biopharmaceutical manufacturing facilities in Vienna (Austria), Biberach (Germany) and St. Joseph/Missouri (USA).

Centres of excellence

Boehringer Ingelheim in Biberach, Germany
BI PHARMA GmbH & Co. KG - Biberach (Germany) Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach (Germany), has Europe's largest biopharmaceutical plant for the development and manufacture of therapeutic proteins from mammalian cell cultures. Biberach is a major Fill & Finish site for biopharmaceuticals. Three of the world's best-selling biotechnology products are produced at this site today. The plant received the Industrial Excellence Award 2000 for Best Factory from the INSEAD Management Institute in France and Germany's WHU-Otto Beisheim School of Management.

Contact information
Boehringer Ingelheim Pharma GmbH & Co. KG
GFB Biopharmaceuticals
Birkendorfer Straße 65
88397 Biberach/Riß
Germany

www.boehringer-ingelheim.de
Boehringer Ingelheim in Vienna, Austria
Boehringer Ingelheim Austria GmbH - Vienna (Austria) Boehringer Ingelheim RCV GmbH & Co KG (Vienna), produces therapeutically active proteins from micro-organisms and yeast with state-of-the-art fermentation technologies. Other areas of production include microbial vaccines, plasmid DNA for gene therapy, protein scaffolds and antibody fragments. One of the top twenty biopharmaceutical blockbusters is manufactured at this plant. The site received the Frost & Sullivan Technoloy Leadership Award and the Customer Value Award 2004 for its provision of superior contract manufacturing services to customers across the globe.

Contact information
Boehringer Ingelheim RCV GmbH & Co KG
Customer Relations & Projects
Dr. Boehringer Gasse 5 - 11
1121 Vienna
Austria

www.boehringer-ingelheim.at
Boehringer Ingelheim in St. Joseph, USA
Boehringer Ingelheim Vetmedica Inc. - St. Joseph/Missouri (USA) At Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri, USA, we manufacture and market biotechnically produced veterinary vaccines for the world market. All technologies and processes have been developed at Boehringer Ingelheim Pharma GmbH & Co. KG in Germany and are also applicable for manufacturing human vaccines.

Contact information
Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506-2002
USA

www.bi-vetmedica.com